Long-term survival after dose-dense high-dose chemotherapy with progenitor cell support as primary treatment for patients with advanced ovarian cancer

被引：0
|
作者：
Eisenhauer, E. L. [1 ]
Tew, W. P. [1 ]
Sabbatini, P. J. [1 ]
Spriggs, D. R. [1 ]
Chi, D. S. [1 ]
Barakat, R. R. [1 ]
Aghajanian, C. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
90
引用
收藏
页码：S41 / S42
页数：2
相关论文
共 50 条
  • [1] Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
    Aghajanian, C
    Fennelly, D
    Shapiro, F
    Waltzman, R
    Almadrones, L
    O'Flaherty, C
    O'Conner, K
    Venkatraman, E
    Barakat, R
    Curtin, J
    Brown, C
    Reich, L
    Wuest, D
    Norton, L
    Hoskins, W
    Spriggs, DR
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1852 - 1860
  • [2] Dose-dense chemotherapy in advanced ovarian cancer
    Bookman, Michael A.
    LANCET, 2009, 374 (9698): : 1303 - 1305
  • [3] High-dose chemotherapy - High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results
    Salerno, MG
    Ferrandina, G
    Greggi, S
    Pierelli, L
    Menichella, G
    Leone, G
    Scambia, G
    Mancuso, S
    BONE MARROW TRANSPLANTATION, 2001, 27 (10) : 1017 - 1025
  • [4] Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment
    Breidenbach, M
    Rein, DT
    Mallmann, P
    Kurbacher, CM
    ANTI-CANCER DRUGS, 2002, 13 (02) : 173 - 176
  • [5] High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results
    MG Salerno
    G Ferrandina
    S Greggi
    L Pierelli
    G Menichella
    G Leone
    G Scambia
    S Mancuso
    Bone Marrow Transplantation, 2001, 27 : 1017 - 1025
  • [6] Controversies on the treatment of ovarian cancer with dose-dense chemotherapy
    Suarez-Zaizar, Alberto
    Cardenas-Cardenas, Eduardo
    Araceli Barajas-Castro, Yadira
    Cortes-Esteban, Patricia
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [7] Long-term survival after high-dose salvage chemotherapy in patients with germ cell tumors
    Rick, O
    Beyer, J
    Schwella, N
    Kingreen, D
    Kirsch, A
    Schleicher, J
    Krusch, A
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1998, 21 : S228 - S228
  • [8] Tandem high-dose chemotherapy versus dose-dense conventional chemotherapy in high-risk breast cancer: predictors of long-term outcome.
    Nitz, U
    Gluz, O
    Mohrmann, S
    Werner, F
    Brandt, M
    Poremba, C
    Diallo, R
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S102 - S102
  • [9] High-dose chemotherapy with autologous stem cell support in advanced ovarian cancer
    Grenman, SE
    Rantanen, VT
    Salmi, TA
    ANNALS OF MEDICINE, 1996, 28 (02) : 151 - 158
  • [10] HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOR PATIENTS WITH EPITHELIAL OVARIAN-CANCER
    KOTZ, KW
    SCHILDER, RJ
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 250 - 262
12345